| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |